Topics
Breast Cancer
Gastrointestinal Cancer
- Colorectal Cancer
- Hepatocellular Cancer
- Pancreatic Cancer
Genitourinary Cancer
- Prostate Cancer
- Renal Cell Carcinoma
Glioblastoma
Gynecologic Cancer
- Ovarian Cancer
Head & Neck Cancer
Hematologic Malignancies
- Leukemias
- Lymphomas
- Multiple Myeloma
Lung cancer
Skin Cancer
Translational Research
Supportive Care
Conference Coverage
2013 Gastrointestinal Cancers Symposium
2012 American Society of Hematology Annual Meeting
2012 San Antonio Breast Cancer Symposium
2012 American Society of Clinical Oncology Annual Meeting
2012 Genitourinary Cancers Symposium
More...
Education
ClinicalThought™ Highlights Module 2
ClinicalQuiz™: Metastatic Breast Cancer Edition
Research Focus: Agents Targeting Novel B-Cell Pathways in Hematologic Malignancies
ClinicalQuiz™: Non-Small-Cell Lung Cancer, Educational Material
2013 GI Symposium
More...
ClinicalThought
Adding Radium-223 to Our Current Treatment Paradigm for Metastatic CRPC: My Thoughts
CML: Why Early Response Matters
What Is the Best Approach in MDS When Hypomethylating Agents Fail?
Bladder Cancer: Are Changes in Chemotherapy Warranted?
How I Manage Patients With Relapsed/Refractory T-Cell Lymphomas
More...
Decision Support
inPractice
Decision Support Tools
Guidelines
CCO Live Events
Slidesets & Resources
Audio
Cases
CCO Store
Expert Viewpoints
NCCN Cases
Oncology Nursing
Slidesets
Video
Save Bookmark
Print
Email to a Colleague
CCO Home
/
Oncology
/
Case Challenges
/
CTCL Cases
/
...
/ Treatment of a 54-Year-Old Male With Tumor-Stage Mycosis Fungoides
Treatment of a 54-Year-Old Male With Tumor-Stage Mycosis Fungoides
Source: CCO Interactive Case Challenges: Diagnosis and Treatment of Cutaneous T-Cell Lymphoma
Table of Contents
Interactive Case Challenges
•
Early-stage CTCL treatment
•
Treatment of a 54-Year-Old Male With Tumor-Stage Mycosis Fungoides
•
Treatment of Recurrent Folliculotropic Mycosis Fungoides in a 37-Year-Old Black Female Patient
Case Challenge
Francine Foss, MD, reviews optimal management of a highly functional patient presenting with de novo tumor-stage mycosis fungoides.
Learning Objectives
Upon completion of this activity, participants should be able to:
Identify the quality-of-life and adverse effect issues involved in first-line treatment of a highly functional patient with tumor-stage mycosis fungoides and preexisting medical conditions
Describe the use of immunosuppressive vs nonimmunosuppressive approaches as second-line treatment for patients with tumor-stage mycosis fungoides
Discuss the use of targeted approaches to treatment in cutaneous T-cell lymphoma
Faculty
Francine Foss
MD
Credit Information
Release Date:
July 25, 2007
Expiration Date:
July 24, 2008
Physicians:
maximum of 0.5
AMA PRA Category 1 Credits
™
Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.
Contact Info
Educational grant provided by:
Educational grants support only the CME-certified components of this program.
Related Content
ClinicalThought™ Highlights Module 2
Understanding the Needs of Younger Patients With Hodgkin’s Lymphoma
How I Manage Patients With Relapsed/Refractory T-Cell Lymphomas
How Do We Improve Current Therapy for MCL? Here Are 4 Promising Possibilities
CML: Why Early Response Matters